MARKET

VCNX

VCNX

Vaccinex Inc
OTCPK
0.590
-0.030
-4.84%
Closed 15:52 03/24 EDT
OPEN
0.600
PREV CLOSE
0.620
HIGH
0.600
LOW
0.590
VOLUME
510
TURNOVER
306
52 WEEK HIGH
13.02
52 WEEK LOW
0.561
MARKET CAP
1.58M
P/E (TTM)
-0.0485
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VCNX last week (0317-0321)?
Weekly Report · 11h ago
Weekly Report: what happened at VCNX last week (0310-0314)?
Weekly Report · 03/17 09:32
Weekly Report: what happened at VCNX last week (0303-0307)?
Weekly Report · 03/10 09:33
Vaccinex to delist common stock from Nasdaq
TipRanks · 03/07 22:25
Vaccinex plans to delist common stock from Nasdaq
Seeking Alpha · 03/07 22:21
Vaccinex Plans to Delist its Common Stock from The Nasdaq Stock Market
Barchart · 03/07 16:15
Weekly Report: what happened at VCNX last week (0224-0228)?
Weekly Report · 03/03 09:33
Weekly Report: what happened at VCNX last week (0217-0221)?
Weekly Report · 02/24 09:33
More
About VCNX
Vaccinex, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including neurodegenerative diseases, cancer, and autoimmune disorders. Its lead product candidate, pepinemab, is in clinical development for the treatment of Alzheimer’s disease, head and neck, pancreatic and breast cancer. Its lead platform technologies include SEMA4D antibody platform and ActivMAb antibody discovery platform. SEMA4D antibody platform is the application of its knowledge of SEMA4D biology to develop pepinemab for the treatment of various diseases and conditions, including cancer. ActivMAb antibody discovery platform is a human antibody discovery platform based on a method for expressing multipass membrane proteins, as well as large and diverse libraries of high affinity, full-length human monoclonal antibodies on the surface of mammalian pox viruses.

Webull offers Vaccinex Inc stock information, including OTCPK: VCNX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VCNX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VCNX stock methods without spending real money on the virtual paper trading platform.